SNTI
Senti Biosciences, Inc.
There isn't enough reported data to score SNTI yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SNTI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
SNTI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SNTI PE Valuation
SNTI has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SNTI Forward outlook
There aren't enough analyst estimates for SNTI to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SNTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$27.34 | -$6.04 |
| Q2 2024 | -$24.43 | -$2.73 |
| Q1 2024 | -$26.18 | -$0.08 |
SNTI is still losing money, but far less than before: $1.79 per share over the past year, against $27.78 at its worst in late 2023.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over SNTI in the latest year-over-year earnings comparison.
SNTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2023 | $338K | -81% |
| Q2 2023 | $937K | -31% |
| Q4 2022 | $59K | -93% |
| Q4 2021 | $793K | +39550% |
SNTI's revenue has slid since its 2022 peak: $17,000 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -85229% | N/A |
| Q1 2026 | -28850% | N/A |
| Q3 2023 | -12981% | -12014 points |
| Q2 2023 | -2096% | -492 points |
| Q1 2023 | -1542% | N/A |
| Q4 2022 | -33925% | -32553 points |
| Q3 2022 | -967% | N/A |
| Q2 2022 | -1603% | N/A |
SNTI's operating margin was −85229% last quarter, down 83687 points from the same quarter a year ago, near the bottom of its range since 2020.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over SNTI on profitability, with a higher operating margin.
SNTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$7.5M | +$6.6M |
| Q4 2025 | -$6.9M | +$6.6M |
| Q3 2025 | -$9.4M | -$1.6M |
| Q2 2025 | -$13.3M | -$4.9M |
| Q1 2025 | -$14.1M | -$2.4M |
| Q4 2024 | -$13.5M | -$6.5M |
| Q3 2024 | -$7.9M | +$9.4M |
| Q2 2024 | -$8.3M | +$9M |
SNTI has the stronger cash trend. Its trailing FCF is up 34% versus its history, compared with UNH at up 5.2%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
SNTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +173K shares |
| 1 year | +211% | +21.1M shares |
| 3 years | +607% | +26.7M shares |
SNTI has 31M diluted shares, up 211% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over SNTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
SNTI Net Leverage
SNTI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SNTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.7 | Oversold |
| Stochastic | 3.2 | Oversold |
SNTI's weekly RSI is 25 (oversold) and its Stochastic is 3 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SNTI PE vs Healthcare Sector
SNTI has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SNTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.23 | 35% below |
| 20 week MA | $0.38 | 61% below |
| 50 week MA | $0.77 | 81% below |
| 100 week MA | $1.79 | 92% below |
| 200 week MA | $3.87 | 96% below |
SNTI is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SNTI on trend strength, trading above more of its moving averages.
SNTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $100.0 | $98.5 | -1.5% |
| 2022 | $98.5 | $13.4 | -86% |
| 2023 | $13.4 | $6.60 | -51% |
| 2024 | $6.60 | $3.92 | -41% |
| 2025 | $3.92 | $1.06 | -73% |
| 2026 YTD | $1.06 | $0.15 | -86% |
SNTI has finished every year since 2021 lower, and it's down 86% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SNTI on returns for 2026, with the stronger performance.